Catalyst Wire Dossier Catalyst Wire Dossier

PiggyBac CD-19 CAR T-cell therapy

CD19-targeted CAR T cells using PiggyBac transposon · Chulalongkorn University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PiggyBac CD-19 CAR T-cell therapy, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus. [Phase 1]

See pricing